
NEW research suggests earlier testing for blood clots in people who have received the AstraZeneca coronavirus vaccine could improve detection and treatment outcomes in those that go on to develop the rare complication. The study suggests the current guidance approach could be missing cases of blood clots.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.